Systemic Lupus Erythematosus Medication Market

Drugs used to treat systemic lupus erythematosus.

Systemic Lupus Erythematosus Medication Market contains market size and forecasts of Systemic Lupus Erythematosus (SLE) Medication in global, including the following market information:

Global Systemic Lupus Erythematosus (SLE) Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Systemic Lupus Erythematosus (SLE) Medication Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Systemic Lupus Erythematosus (SLE) Medication companies in 2021 (%)

The global Systemic Lupus Erythematosus (SLE) Medication market was valued at 200 million in 2021 and is projected to reach US$ 272.6 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Systemic Lupus Erythematosus (SLE) Medication include GSK, ImmuPharma, Merck Serono, UCB, Amgen, HGS, Immunomedics, MedImmune and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Systemic Lupus Erythematosus (SLE) Medication manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Systemic Lupus Erythematosus (SLE) Medication Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, by Type, 2021 (%)

Corticosteroids

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Anti-Inflammatories

Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Antimalarials

BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS)

Immunosuppressive Agents/Immune Modulators

Anticoagulants

Global Systemic Lupus Erythematosus (SLE) Medication Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, by Application, 2021 (%)

Intravenous

Oral

Topical

Others

Global Systemic Lupus Erythematosus (SLE) Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Systemic Lupus Erythematosus (SLE) Medication Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Systemic Lupus Erythematosus (SLE) Medication revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Systemic Lupus Erythematosus (SLE) Medication revenues share in global market, 2021 (%)

Key companies Systemic Lupus Erythematosus (SLE) Medication sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Systemic Lupus Erythematosus (SLE) Medication sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

ImmuPharma

Merck Serono

UCB

Amgen

HGS

Immunomedics

MedImmune

Sanofi